Renaissance Technologies - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$20,438,000
-10.0%
542,548
-59.4%
0.02%0.0%
Q4 2020$22,706,000
+184.8%
1,334,848
-21.3%
0.02%
+212.5%
Q3 2020$7,972,000
-25.1%
1,696,186
-2.7%
0.01%
-11.1%
Q2 2020$10,639,000
+137.7%
1,744,048
-11.6%
0.01%
+125.0%
Q1 2020$4,476,000
-44.7%
1,971,917
+11.9%
0.00%
-33.3%
Q4 2019$8,087,000
+56.3%
1,761,971
+32.0%
0.01%
+50.0%
Q3 2019$5,173,000
-25.4%
1,334,891
+16.2%
0.00%
-33.3%
Q2 2019$6,930,000
-16.1%
1,149,200
+86.5%
0.01%
-25.0%
Q1 2019$8,256,000
+83.5%
616,100
+27.4%
0.01%
+60.0%
Q4 2018$4,498,000
+115.4%
483,705
+222.5%
0.01%
+150.0%
Q3 2018$2,088,000
-78.9%
150,000
-74.7%
0.00%
-60.0%
Q2 2018$9,881,000
+55.8%
593,000
+60.6%
0.01%
-28.6%
Q1 2018$6,343,000
+119.3%
369,200
+422.2%
0.01%
+133.3%
Q3 2017$2,892,000
-77.7%
70,700
-83.6%
0.00%
-82.4%
Q2 2017$12,992,000
-22.4%
431,500
-6.8%
0.02%
-26.1%
Q1 2017$16,734,000
+516.6%
462,901
+795.4%
0.02%
+360.0%
Q3 2016$2,714,000
-45.9%
51,700
-57.4%
0.01%
-50.0%
Q2 2016$5,016,000
-47.1%
121,300
-48.0%
0.01%
-44.4%
Q1 2016$9,479,000
-27.1%
233,300
-25.5%
0.02%
-35.7%
Q4 2015$12,998,000
+2596.7%
313,200
+900.6%
0.03%
+2700.0%
Q3 2015$482,000
-88.2%
31,300
-81.0%
0.00%
-88.9%
Q2 2015$4,089,000
+25.0%
164,600
+14.9%
0.01%
+28.6%
Q1 2015$3,272,000143,2000.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders